Conference
A randomized phase I clinical and biologic study of two schedules of BAY 43-9006 in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): A National Cancer Institute of Cancer Clinical Trials Group Study.
Authors
Crump M; Leber B; Kassis J; Hedley D; Minden M; Buckstein R; McIntosh L; Eisenhauer E; Seymour L
Volume
22
Pagination
pp. 585S-585S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
July 15, 2004
Name of conference
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
New Orleans, LA
Conference start date
June 5, 2004
Conference end date
June 8, 2004
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
14
ISSN
0732-183X